5,7,8,15-TETRAHYDRO-4-HYDROXY-3-METHOXY-6-METHYL(1,3)BENZODIOXOLO(5,6-E)(2)BENZAZECIN-14(6H)-ONE
UNII S9TC6BMK2V
Substance Identification & Data
This profile provides standardized clinical and technical data for 5,7,8,15-tetrahydro-4-hydroxy-3-methoxy-6-methyl(1,3)benzodioxolo(5,6-e)(2)benzazecin-14(6h)-one, uniquely identified by the FDA Unique Ingredient Identifier (UNII) S9TC6BMK2V.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 490-52-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C20H21NO5 RSMSJQDBPYSXHH-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 5,7,8,15-tetrahydro-4-hydroxy-3-methoxy-6-methyl(1,3)benzodioxolo(5,6-e)(2)benzazecin-14(6h)-one. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.